China Life Insurance Company Limited logo

China Life Insurance Company Limited

2628.HK

HKSEFinancial ServicesInsurance - Life

Latest quote

HK$28.66

+HK$0.60 · +2.14%

Aug 24, 4:08 PM HKT

2628.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Operating across the People's Republic of China, China Life Insurance Company Limited, supported by its various subsidiaries, serves as a prominent provider of life insurance services. The company structures its extensive operations into four principal divisions: Life Insurance, Health Insurance, Accident Insurance, and a category for Other Businesses. It offers a wide array of protective insurance products, which include critical illness coverage, annuity schemes, specialized policies targeting children, women, and pension planning, in addition to general security, life, medical, and accident safeguards. The firm's origins trace back to 1949, and its central office is situated in Beijing, PRC. Ultimately, China Life Insurance Company Limited is an integral part of the China Life Insurance (Group) Company Limited, operating as one of its subsidiaries.

Industry
Insurance - Life
Sector
Financial Services
Headquarters
CN
CEO
Li Mingguang
Listed since
Dec 18, 2003
Employees
97,505

Market position

Day range

Current HK$28.66

52-week range

Current HK$28.66

Open
HK$28.12
Previous close
HK$28.06
Volume
58.85M
1.1× average
Average volume
53.47M
Average daily volume
Market cap
1.31T HKD
Beta
0.88
Market reference 1
50-day average
HK$28.3008
+1.27% above average
200-day average
HK$29.0095
-1.20% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
588.74B CNY
P/E (TTM)
7.35×
P/B (TTM)
1.78×
P/S (TTM)
2.04×
EV / EBITDA
3.16×
Earnings yield
22.16%
Free cash flow yield
65.71%
Dividend yield
2.27%

Profitability & efficiency

Gross margin
100.00%
Operating margin
31.88%
Net margin
27.82%
Return on equity
25.89%
Return on assets
2.03%
Return on invested capital
13.42%

Financial health

Debt / equity
0.46×
Current ratio
0.02×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends109%71%32%-7%Gross margin, FY2021: 10.14%Gross margin, FY2022: 8.04%Gross margin, FY2023: 99.56%Gross margin, FY2024: 99.65%Gross margin, FY2025: 99.70%Operating margin, FY2021: 5.94%Operating margin, FY2022: 2.92%Operating margin, FY2023: 13.11%Operating margin, FY2024: 22.49%Operating margin, FY2025: 30.02%Net margin, FY2021: 5.99%Net margin, FY2022: 3.90%Net margin, FY2023: 12.91%Net margin, FY2024: 20.88%Net margin, FY2025: 25.46%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 10.14%. Gross margin FY2022 8.04%. Gross margin FY2023 99.56%. Gross margin FY2024 99.65%. Gross margin FY2025 99.70%. Operating margin FY2021 5.94%. Operating margin FY2022 2.92%. Operating margin FY2023 13.11%. Operating margin FY2024 22.49%. Operating margin FY2025 30.02%. Net margin FY2021 5.99%. Net margin FY2022 3.90%. Net margin FY2023 12.91%. Net margin FY2024 20.88%. Net margin FY2025 25.46%.

Income trends

Revenue

605.11B CNY+18.14%

Operating income

181.63B CNY+57.65%

Net income

154.08B CNY+44.09%
Income trends across reported periods930.52B CNY600.89B CNY271.27B CNY−58.36B CNYRevenue, FY2021: 848.11B CNYRevenue, FY2022: 822.31B CNYRevenue, FY2023: 396.47B CNYRevenue, FY2024: 512.2B CNYRevenue, FY2025: 605.11B CNYOperating income, FY2021: 50.34B CNYOperating income, FY2022: 24.05B CNYOperating income, FY2023: 51.99B CNYOperating income, FY2024: 115.21B CNYOperating income, FY2025: 181.63B CNYNet income, FY2021: 50.77B CNYNet income, FY2022: 32.08B CNYNet income, FY2023: 51.18B CNYNet income, FY2024: 106.94B CNYNet income, FY2025: 154.08B CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 848.11B CNY. Revenue FY2022 822.31B CNY. Revenue FY2023 396.47B CNY. Revenue FY2024 512.2B CNY. Revenue FY2025 605.11B CNY. Operating income FY2021 50.34B CNY. Operating income FY2022 24.05B CNY. Operating income FY2023 51.99B CNY. Operating income FY2024 115.21B CNY. Operating income FY2025 181.63B CNY. Net income FY2021 50.77B CNY. Net income FY2022 32.08B CNY. Net income FY2023 51.18B CNY. Net income FY2024 106.94B CNY. Net income FY2025 154.08B CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue605.11B CNY512.2B CNY396.47B CNY822.31B CNY848.11B CNY
Cost of goods sold1.79B CNY1.8B CNY1.73B CNY756.19B CNY762.12B CNY
Gross profit603.33B CNY510.4B CNY394.74B CNY66.12B CNY85.99B CNY
Selling, general, and administrative−19.53B CNY−19B CNY25.65B CNY24.21B CNY17.02B CNY
Operating expenses421.7B CNY395.19B CNY342.76B CNY42.07B CNY35.65B CNY
Interest income124.13B CNY116.76B CNY
Interest expense126.81B CNY4.86B CNY5.6B CNY
Depreciation and amortization4.89B CNY5.03B CNY5.02B CNY4.93B CNY4.94B CNY
Operating income181.63B CNY115.21B CNY51.99B CNY24.05B CNY50.34B CNY
Net income154.08B CNY106.94B CNY51.18B CNY32.08B CNY50.77B CNY

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
80%
4 beats, 1 miss, 0 met estimates
Average EPS surprise
+69.53%
5 comparable reports
Latest EPS result
0.79

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates5.753.861.970.08Q4 '24No estimateQ4 '24No estimateQ1 '25BeatQ3 '25MissQ4 '25No estimateQ1 '26BeatQ2 '26No estimateQ3 '26Estimate
Q4 2024, reported Oct 30, 2024: actual 2.59, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 31, 2024: actual 0.091, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual 2.59, estimate 2.58, surprise +0.39%, Beat. Q3 2025, reported Aug 27, 2025: actual 0.471, estimate 1.6, surprise -70.59%, Miss. Q4 2025, reported Oct 30, 2025: actual 4.92, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Mar 25, 2026: actual 4.45, estimate 4.11, surprise +8.27%, Beat. Q2 2026, reported Apr 29, 2026: actual 0.786, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 27, 2026: actual —, estimate 5.33, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates278.47B202.13B125.78B49.43BQ4 '24No estimateQ4 '24No estimateQ1 '25MissQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26MissQ3 '26Estimate
Q4 2024, reported Oct 30, 2024: actual 210.1B HKD, estimate —, surprise —, Comparison unavailable. Q4 2024, reported Dec 31, 2024: actual 58.15B HKD, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Mar 26, 2025: actual 193.59B HKD, estimate 194.03B HKD, surprise -0.23%, Miss. Q3 2025, reported Aug 27, 2025: actual 262.15B HKD, estimate 173.99B HKD, surprise +50.67%, Beat. Q4 2025, reported Oct 30, 2025: actual 189.78B HKD, estimate 134.46B HKD, surprise +41.14%, Beat. Q1 2026, reported Mar 25, 2026: actual 227.92B HKD, estimate 203.4B HKD, surprise +12.05%, Beat. Q2 2026, reported Apr 29, 2026: actual 102.62B HKD, estimate 103.62B HKD, surprise -0.96%, Miss. Q3 2026, reported Aug 27, 2026: actual —, estimate 191.78B HKD, surprise —, Comparison unavailable.

2628.HK peers

Continue in GoAI

Research 2628.HK

research.disclaimer